Immunotherapeutic effects ofMycobacterium tuberculosis rv3407DNA vaccine in mice
- 17 November 2018
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 51 (8) , 417-422
Abstract
Tuberculosis (TB) is a major global public health problem. Latent TB infection (LTBI) is a major source of active TB. New vaccines to treat LTBI are urgently demanded. In this study, the gene encoding latency-associated antigen Rv3407 of Mycobacterium tuberculosis (MTB) rv3407 DNA vaccine was used to prepare and the immunogenicity and therapeutic effects were evaluated. Normal mice were immunized intramuscularly three times at two-week intervals with sterile water for injection, plasmid vector pVAX1, M. vaccae vaccine, ag85a DNA or rv3407 DNA. TB-infected mice were immunized intramuscularly three times at two-week intervals with phosphate-buffered saline (PBS) and rv3407 DNA. The normal mice immunized with rv3407 DNA or ag85a DNA showed higher levels of interferon-gamma (IFN-γ) in stimulated spleen lymphocyte culture supernatants, and had more Th1 cells and an elevated ratio of Th1/Th2 immune cells in whole blood, indicating that a Th1-type immune response was predominant. The levels of anti-Ag85A or anti-Rv3407 IgG antibody were significantly increased in the ag85a DNA and rv3407 DNA groups compared to the sterile water for injection, vector, and M. vaccae groups (p < .0001). Compared with the PBS group, the rv3407 DNA group had pulmonary bacterial loads that were lower by 0.56 log10 (p < .01). The mice vaccinated with rv3407 DNA developed antigen-specific cellular and humoral responses. The rv3407 DNA is a potential DNA vaccine candidate against TB.Keywords
Funding Information
- Serious Infectious Diseases Special Foundation of China (002)
- 309th Hospital of Chinese PLA
This publication has 29 references indexed in Scilit:
- Treatment of Multi‐Drug‐Resistant Tuberculosis in Mice with DNA Vaccines Alone or in Combination with Chemotherapeutic DrugsScandinavian Journal of Immunology, 2011
- A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen RepertoireClinical and Vaccine Immunology, 2009
- Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis InfectionPLOS ONE, 2009
- Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83Gene Therapy, 2008
- The resuscitation‐promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitroMolecular Microbiology, 2007
- Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosisGene Therapy, 2005
- Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosisGene Therapy, 2003
- Lymphocyte responses and cytokinesCell, 1994
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.Journal of Experimental Medicine, 1993
- The global tuberculosis situation and the new control strategy of the World Health OrganizationTubercle, 1991